Bio-Techne Is a Top S&P 500 Stock. Germany’s Merck Is Paying a 24% Premium for the Company.

Bio-Techne Is a Top S&P 500 Stock. Germany’s Merck Is Paying a 24% Premium for the Company.

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance.